Akouos, Inc.
METHODS OF TREATING CLRN1-ASSOCIATED HEARING LOSS AND/OR VISION LOSS
Last updated:
Abstract:
Provided herein are compositions that include a single nucleic acid vector or two different nucleic acid vectors, and the use of these compositions to treat hearing loss and/or vision loss in a subject.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
9 Sep 2021